1492 Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

1492 Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.96 - $2.93 $22,881 - $34,204	11,674 Added 2.39%	501,050 $1.29 Million
Q2 2022 Aug 10, 2022	SELL	$1.73 - $3.09 $35,381 - $63,196	-20,452 Reduced 4.01%	489,376 $944,000
Q1 2022 May 12, 2022	BUY	$2.94 - $4.77 $55,257 - $89,652	18,795 Added 3.83%	509,828 $1.51 Million
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $11,086 - $14,437	2,724 Added 0.56%	491,033 $2.21 Million
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $1.7 Million - $2.62 Million	361,309 Added 284.5%	488,309 $2.37 Million
Q2 2021 Aug 13, 2021	BUY	$6.81 - $10.93 $864,870 - $1.39 Million	127,000 New	127,000 $866,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.